Enhancing effects of quinacrine on development of hepatopancreatic lesions in N-nitrosobis(2-oxopropyl)amine-initiated hamsters

Japanese Journal of Cancer Research : Gann
F FurukawaM Takahashi

Abstract

The modifying effects of quinacrine administration during the post-initiation phase of carcinogenesis were investigated in hamsters treated with N-nitrosobis(2-oxopropyl)amine (BOP). Female Syrian hamsters were given three weekly s.c. injections of BOP at a dose of 10 mg/kg and then 300 or 100 ppm quinacrine in their diet for 37 weeks. Additional groups of animals received the BOP injection alone, or only the 300 ppm quinacrine treatment as BOP-negative controls. At week 40 of the experiment, all surviving animals were killed and development of proliferative lesions was assessed histopathologically. The multiplicity of pancreatic adenocarcinomas and dysplastic lesions per hamster was significantly higher (P<0.01 and P<0.05) in the BOP/Q100 group (1.92 and 1.78) than in the BOP-alone group (1.07 and 0.79). The incidence of hepatocellular adenomas plus carcinomas was also significantly elevated (P<0.05) in the BOP/Q300 and BOP/Q100 groups. In contrast, the multiplicity of lung adenomas plus adenocarcinomas was significantly decreased (P<0.05) by the Q300 treatment. Neither the incidence nor the multiplicity of renal cell tumors (adenomas and carcinomas) or nephroblastomas significantly differed between the BOP-treated groups. Ele...Continue Reading

References

Jan 1, 1978·Biochemical Pharmacology·H LüllmannO Wassermann
Jan 5, 1978·Nature·T Yorio, P J Bentley
Feb 1, 1976·Biochemical Pharmacology·R J Flower, G J Blackwell
May 1, 1977·Journal of the National Cancer Institute·P PourU Mohr
May 1, 1975·Journal of Bacteriology·T M Cook, C K Goldman
Mar 1, 1990·The Journal of Membrane Biology·M AkabasQ al-Awqati
Jan 1, 1985·Cancer Chemotherapy and Pharmacology·H R Hartmann, W Bollag
Dec 1, 1985·Annals of the Rheumatic Diseases·W GibbM L Snaith
Sep 15, 1974·Biochemical Pharmacology·C de DuveF Van Hoof
Aug 1, 1972·Acta Pathologica Japonica·T ShikataK Nagashima
Dec 17, 1969·Biochimica Et Biophysica Acta·H B Markus, E G Ball
Dec 1, 1983·British Journal of Cancer·D L McCormick, R C Moon
Jan 1, 1993·Archives of Toxicology·A González PadrónJ A Castro

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alagille Syndrome

Alagille syndrome is a multi-system genetic disorder that can affect the liver, heart, and other parts of the body. It’s characterization includes heart problems, liver damage, jaundice, and xanthomas. Here is the latest research.

Adrenocortical Carcinoma

Hepatocellular carcinoma is the most common type of primary liver cancer and frequently occurs in individuals with chronic liver diseases like cirrhosis. Here is the latest research.

Adenoma, Liver Cell

Liver Cell Adenoma or hepatic adenoma is a rare benign tumor. It is associated with birth control use or pregnancy. Discover the latest research on Liver Cell Adenoma here.

Carcinoma, Hepatocellular

Hepatocellular Carcinoma is a malignant cancer in liver epithelial cells. Discover the latest research on Hepatocellular Carcinoma here.